Apogee Therapeutics, Inc. 10-Q filing
Filed 2025-11-10 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001193125-25-273260
- Form type
- 10-Q
- CIK
- 0001974640
- Primary document
- https://www.sec.gov/Archives/edgar/data/1974640/000119312525273260/apge-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Apogee Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-207.5M | - | - |
| Net Income | $-186.5M | - | - |
| Eps Basic | -3.19 | - | - |
| Eps Diluted | -3.19 | - | - |
| Cash And Equivalents | $107.9M | - | - |
| Total Assets | $626.2M | - | - |
| Total Liabilities | $39.8M | - | - |
| Operating Cash Flow | $-164.8M | - | - |
| Capital Expenditures | $5.1M | - | - |